683 Capital Management, LLC Buys Penn Virginia Corp, Adient PLC, Syros Pharmaceuticals Inc, Sells uniQure NV, PG&E Corp, Scorpio Tankers Inc

• New Purchases: PVAC, SYRS, GM, CDLX, ROAN, MBIO, BCEI, PTE, AFMD, ONM2, XBIT, NVUS, CHAP,
• Added Positions: ADNT, DSSI, ADMA, EIGR, ALDX, ENVA, MDCO, ARDX, ALNY, ONDK, MGNX, TNK, SRRA, SLS, SBBP, SNDX, IRCP, SQBG, CMRX, GNK,
• Reduced Positions: QURE, PCG, STNG, TRUE, GX1N, FATE, ELVT, BHF, GSAT, TGTX, ZIOP, NM,
• Sold Out: BX, NTEC, APVO, ACER, ONCS, MR, USWS, CPLP,

For the details of 683 Capital Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/683+capital+management%2C+llc/current-portfolio/portfolio

1. Carvana Co (CVNA) - 1,965,000 shares, 11.44% of the total portfolio.
2. Tesla Inc (TSLA) - 380,500 shares, 7.91% of the total portfolio.
3. The Hershey Co (HSY) - 350,000 shares, 4.36% of the total portfolio.
4. PG&E Corp (PCG) - 1,950,000 shares, 4.16% of the total portfolio. Shares reduced by 24.65%
5. uniQure NV (QURE) - 500,000 shares, 3.63% of the total portfolio. Shares reduced by 33.33%

683 Capital Management, LLC initiated holding in Penn Virginia Corp. The purchase prices were between $27.86 and $46.18, with an estimated average price of $37.23. The stock is now traded at around $31.44. The impact to a portfolio due to this purchase was 1.48%. The holding were 520,000 shares as of .

683 Capital Management, LLC initiated holding in Syros Pharmaceuticals Inc. The purchase prices were between $5.5 and $9.75, with an estimated average price of $6.96. The stock is now traded at around $10.98. The impact to a portfolio due to this purchase was 0.37%. The holding were 429,775 shares as of .

683 Capital Management, LLC initiated holding in General Motors Co. The purchase prices were between $33.34 and $40.3, with an estimated average price of $37.5. The stock is now traded at around $36.96. The impact to a portfolio due to this purchase was 0.36%. The holding were 100,000 shares as of .

683 Capital Management, LLC initiated holding in Cardlytics Inc. The purchase prices were between $14.58 and $25.98, with an estimated average price of $19.98. The stock is now traded at around $32.50. The impact to a portfolio due to this purchase was 0.28%. The holding were 117,891 shares as of .

683 Capital Management, LLC initiated holding in Roan Resources Inc. The purchase prices were between $1.16 and $5.9, with an estimated average price of $3.61. The stock is now traded at around $1.18. The impact to a portfolio due to this purchase was 0.24%. The holding were 1,475,837 shares as of .

683 Capital Management, LLC initiated holding in Mustang Bio Inc. The purchase prices were between $2.66 and $6.28, with an estimated average price of $3.83. The stock is now traded at around $4.05. The impact to a portfolio due to this purchase was 0.21%. The holding were 625,000 shares as of .

683 Capital Management, LLC added to a holding in Adient PLC by 51.21%. The purchase prices were between $14.37 and $25.91, with an estimated average price of $20.61. The stock is now traded at around $22.43. The impact to a portfolio due to this purchase was 0.62%. The holding were 812,000 shares as of .

683 Capital Management, LLC added to a holding in Diamond S Shipping Inc by 198.04%. The purchase prices were between $9.65 and $14.23, with an estimated average price of $12.38. The stock is now traded at around $10.79. The impact to a portfolio due to this purchase was 0.24%. The holding were 300,200 shares as of .

683 Capital Management, LLC added to a holding in ADMA Biologics Inc by 76.94%. The purchase prices were between $3.52 and $5.24, with an estimated average price of $4.42. The stock is now traded at around $4.06. The impact to a portfolio due to this purchase was 0.22%. The holding were 1,424,378 shares as of .

683 Capital Management, LLC added to a holding in The Medicines Co by 28.55%. The purchase prices were between $27.53 and $37.25, with an estimated average price of $32.61. The stock is now traded at around $32.83. The impact to a portfolio due to this purchase was 0.16%. The holding were 215,000 shares as of .

683 Capital Management, LLC added to a holding in Ardelyx Inc by 39.17%. The purchase prices were between $2.49 and $3.73, with an estimated average price of $3.01. The stock is now traded at around $3.14. The impact to a portfolio due to this purchase was 0.1%. The holding were 1,442,346 shares as of .

683 Capital Management, LLC added to a holding in Teekay Tankers Ltd by 42.50%. The purchase prices were between $0.94 and $1.4, with an estimated average price of $1.14. The stock is now traded at around $1.07. The impact to a portfolio due to this purchase was 0.05%. The holding were 1,425,000 shares as of .

683 Capital Management, LLC sold out a holding in Blackstone Group Inc. The sale prices were between $34.45 and $45.04, with an estimated average price of $39.87.

683 Capital Management, LLC sold out a holding in Intec Pharma Ltd. The sale prices were between $4.13 and $7.68, with an estimated average price of $5.64.

683 Capital Management, LLC sold out a holding in Aptevo Therapeutics Inc. The sale prices were between $0.7 and $0.97, with an estimated average price of $0.81.

683 Capital Management, LLC sold out a holding in Acer Therapeutics Inc. The sale prices were between $3.45 and $26.86, with an estimated average price of $19.07.

683 Capital Management, LLC sold out a holding in OncoSec Medical Inc. The sale prices were between $2.38 and $6.7, with an estimated average price of $4.37.

683 Capital Management, LLC sold out a holding in Montage Resources Corp. The sale prices were between $6.02 and $15.06, with an estimated average price of $10.01.